{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:09:16Z","timestamp":1790212156134,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["D13C22003520001"],"award-info":[{"award-number":["D13C22003520001"]}],"id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007388","name":"St Paul Foundation","doi-asserted-by":"publisher","award":["D13C25000220007"],"award-info":[{"award-number":["D13C25000220007"]}],"id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017336","name":"Dipartimenti di Eccellenza","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010688","name":"Horizon 2020 European Innovation Council Fast Track to Innovation","doi-asserted-by":"publisher","award":["964934"],"award-info":[{"award-number":["964934"]}],"id":[{"id":"10.13039\/100010688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jconrel.2026.115270","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:59:20Z","timestamp":1787065160000},"page":"115270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nose-to-brain delivery of a novel boronated curcuminoid via cyclodextrins: Biodistribution toward potential BNCT applications in Alzheimer's disease"],"prefix":"10.1016","volume":"398","author":[{"given":"Diego","family":"Alberti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Micocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Lanfranco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Elkhanoufi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Bitonto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julieta N.","family":"Pi\u00f1a Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Protti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Deagostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Geninatti Crich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115270_bb0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","article-title":"The global burden of neurological disorders: translating evidence into policy","volume":"19","author":"Feigin","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jconrel.2026.115270_bb0010","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.arcmed.2014.11.020","article-title":"Cyclodextrins, blood-brain barrier, and treatment of neurological diseases","volume":"45","author":"Vecserny\u00e9s","year":"2014","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.jconrel.2026.115270_bb0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115270_bb0020","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.7150\/thno.41161","article-title":"Multimodal and multiscale optical imaging of nanomedicine delivery across the blood-brain barrier upon sonopermeation","volume":"10","author":"May","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115270_bb0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jconrel.2026.115270_bb0030","article-title":"On a highway to the brain: a review on nose-to-brain drug delivery using nanoparticles","volume":"29","author":"Formica","year":"2022","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.jconrel.2026.115270_bb0035","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115270_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/17425247.2025.2569644","article-title":"Can nanoparticle-based intranasal delivery systems revolutionize treatment of central nervous system diseases?","volume":"23","author":"Nunziata","year":"2026","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115270_bb0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115270_bb0050","first-page":"13","article-title":"Biopolymer nanoparticles for nose-to-brain drug delivery: a new promising approach for the treatment of neurological diseases","author":"Montegiove","year":"2022","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.jconrel.2026.115270_bb0055","doi-asserted-by":"crossref","first-page":"17947","DOI":"10.1039\/D5NR00870K","article-title":"Polymeric nanoparticles for efficient nose-to-brain delivery","volume":"17","author":"Bolon","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2026.115270_bb0060","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.2147\/DDDT.S447496","article-title":"Advances in nanotechnology for enhancing the solubility and bioavailability of poorly soluble drugs","volume":"18","author":"Liu","year":"2024","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2026.115270_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.10.044","article-title":"Cyclodextrins and their pharmaceutical applications","volume":"329","author":"Loftsson","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115270_bb0070","doi-asserted-by":"crossref","first-page":"10940","DOI":"10.1021\/cr500081p","article-title":"Review: a history of cyclodextrins","volume":"114","author":"Crini","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.115270_bb0075","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/cr970022c","article-title":"Introduction and general overview of cyclodextrin chemistry","volume":"98","author":"Szejtli","year":"1998","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.115270_bb0080","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1002\/jps.23077","article-title":"Cyclodextrins as functional excipients: methods to enhance complexation efficiency","volume":"101","author":"Loftsson","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115270_bb0085","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.bbamem.2007.03.026","article-title":"Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies","volume":"1768","author":"Zidovetzki","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2026.115270_bb0090","article-title":"Carboranyl-curcuminoids for the neutron capture-based treatment of amyloid aggregates in Alzheimer\u2019s disease","author":"Micocci","year":"2026","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.jconrel.2026.115270_bb0095","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1093\/brain\/awad159","article-title":"The amyloid cascade hypothesis: an updated critical review","volume":"146","author":"Kepp","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.jconrel.2026.115270_bb0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.14338\/IJPT-22-00002.1","article-title":"A review of boron neutron capture therapy: its history and current challenges","volume":"9","author":"Jin","year":"2022","journal-title":"Int. J. Part. Ther."},{"key":"10.1016\/j.jconrel.2026.115270_bb0105","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1080\/09553002.2024.2373746","article-title":"A clinician's perspective on boron neutron capture therapy: promising advances, ongoing trials, and future outlook","volume":"100","author":"Shen","year":"2024","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.jconrel.2026.115270_bb0110","article-title":"Boron neutron capture therapy at a crossroads: translational gap and emerging delivery agents","author":"Selg","year":"2026","journal-title":"Chemistry"},{"key":"10.1016\/j.jconrel.2026.115270_bb0115","first-page":"160","article-title":"New boron delivery agents","volume":"38","author":"Beck-Sickinger","year":"2023","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.jconrel.2026.115270_bb0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jconrel.2023.06.022","article-title":"Efficient neutron capture therapy of glioblastoma with pteroyl-closo-dodecaborate-conjugated 4-(p-iodophenyl)butyric acid (PBC-IP)","volume":"360","author":"Nishimura","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115270_bb0125","article-title":"Nonclinical pharmacodynamics of boron neutron capture therapy using direct intratumoral administration of a folate receptor targeting novel boron carrier","volume":"6","author":"Tsujino","year":"2024","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.jconrel.2026.115270_bb0130","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41598-023-27625-0","article-title":"A novel pH sensitive theranostic PLGA nanoparticle for boron neutron capture therapy in mesothelioma treatment","volume":"13","author":"Sforzi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115270_bb0135","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3390\/ph18040466","article-title":"Enhancing boron neutron capture therapy (BNCT) with materials based on COSAN-functionalized nanoparticles","volume":"18","author":"Ferrer-Ugalde","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jconrel.2026.115270_bb0140","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.7150\/thno.126209","article-title":"Nanobiomaterial-enabled boron delivery systems and innovative strategies for revolutionizing BNCT","volume":"16","author":"Yang","year":"2026","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115270_bb0145","article-title":"Boron neutron capture therapy: research progress and clinical translation of boron nanomedicines","author":"Xie","year":"2026","journal-title":"ACS Nano Med."},{"key":"10.1016\/j.jconrel.2026.115270_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2025.123343","article-title":"Design and evaluation of a supramolecular boron compound using a cyclodextrin-based polyrotaxane for boron neutron capture therapy","volume":"354","author":"Matsumoto","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2026.115270_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116334","article-title":"Combining BNCT with carbonic anhydrase inhibition for mesothelioma treatment: synthesis, in vitro, in vivo studies of ureidosulfamido carboranes","volume":"270","author":"Lanfranco","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115270_bb0160","doi-asserted-by":"crossref","first-page":"19274","DOI":"10.1038\/s41598-020-76370-1","article-title":"In vitro and in vivo BNCT investigations using a carborane containing sulfonamide targeting CAIX epitopes on malignant pleural mesothelioma and breast cancer cells","volume":"10","author":"Alberti","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115270_bb0165","doi-asserted-by":"crossref","first-page":"12970","DOI":"10.1002\/chem.201802134","article-title":"Host-guest chemistry of carboranes: synthesis of carboxylate derivatives and their binding to cyclodextrins","volume":"24","author":"Nekvinda","year":"2018","journal-title":"Chemistry"},{"key":"10.1016\/j.jconrel.2026.115270_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103324","article-title":"Design, synthesis and preliminary in-vitro studies of novel boronated monocarbonyl analogues of curcumin (BMAC) for antitumor and \u03b2-amiloyd disaggregation activity","volume":"93","author":"Azzi","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jconrel.2026.115270_bb0175","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.115270_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.619667","article-title":"Natural compounds as inhibitors of A\u03b2 peptide aggregation: chemical requirements and molecular mechanisms","volume":"14","author":"Pagano","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jconrel.2026.115270_bb0185","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1021\/acschemneuro.5b00214","article-title":"Curcumin attenuates amyloid-\u03b2 aggregate toxicity and modulates amyloid-\u03b2 aggregation pathway","volume":"7","author":"Thapa","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jconrel.2026.115270_bb0190","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1039\/D1CC07000B","article-title":"Detoxification of amyloid \u03b2 fibrils by curcumin derivatives and their verification in a Drosophila Alzheimer\u2019s model","volume":"58","author":"Utomo","year":"2022","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2026.115270_bb0195","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1039\/D0CC01161D","article-title":"Binding modes of thioflavin T and Congo red to the fibril structure of amyloid-\u03b2(1\u201342)","volume":"56","author":"Frieg","year":"2020","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2026.115270_bb0200","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.fct.2005.03.007","article-title":"2-hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review","volume":"43","author":"Gould","year":"2005","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jconrel.2026.115270_bb0205","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1021\/js960213f","article-title":"Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation","volume":"86","author":"Irie","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115270_bb0210","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3390\/pharmaceutics12070658","article-title":"Investigation of cytotoxicity and cell uptake of cationic beta-cyclodextrins as valid tools in nasal delivery","volume":"12","author":"Rassu","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115270_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2024.103322","article-title":"Mucoadhesion across scales: towards the design of protein-based adhesives","volume":"334","author":"Hazt","year":"2024","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.jconrel.2026.115270_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-08727-y","article-title":"Positively charged cyclodextrins as effective molecular transporters of active phosphorylated forms of gemcitabine into cancer cells","volume":"7","author":"Rodriguez-Ruiz","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115270_bb0225","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neurobiolaging.2018.06.002","article-title":"Doxycycline counteracts neuroinflammation restoring memory in Alzheimer\u2019s disease mouse models","volume":"70","author":"Balducci","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jconrel.2026.115270_bb0230","article-title":"Utilization of APPswe\/PS1dE9 transgenic mice in research of Alzheimer\u2019s disease: focus on gene therapy and cell-based therapy applications","volume":"2011","author":"Malm","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.jconrel.2026.115270_bb0235","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.foodres.2011.03.004","article-title":"Green tea catechins during food processing and storage: a review on stability and detection","volume":"50","author":"Ananingsih","year":"2013","journal-title":"Food Res. Int."},{"key":"10.1016\/j.jconrel.2026.115270_bb0240","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1021\/acs.molpharmaceut.5c00382","article-title":"Intranasal delivery of metabolically resilient glutathione: in vivo pharmacokinetic, permeation, and efficacy studies","volume":"22","author":"Bhilare","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115270_bb0245","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115270_bb0250","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1021\/mp0700209","article-title":"The rule of five revisited: applying log D in place of log P in drug-likeness filters","volume":"4","author":"Bhal","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115270_bb0255","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2273.1999.00223.x","article-title":"Nasal pH measurement: a reliable and repeatable parameter","volume":"24","author":"England","year":"1999","journal-title":"Clin. Otolaryngol."},{"key":"10.1016\/j.jconrel.2026.115270_bb0260","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.amjoto.2013.04.015","article-title":"Nasal pH in patients with chronic rhinosinusitis before and after endoscopic sinus surgery","volume":"34","author":"Kim","year":"2013","journal-title":"Am. J. Otolaryngol."},{"key":"10.1016\/j.jconrel.2026.115270_bb0265","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejps.2016.06.024","article-title":"Optimised method to estimate octanol water distribution coefficient (logD) in a high throughput format","volume":"92","author":"Low","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115270_bb0270","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jconrel.2022.08.051","article-title":"Recent advances in drug delivery and targeting to the brain","volume":"350","author":"Sethi","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115270_bb0275","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4155\/fmc-2018-0436","article-title":"Small molecules as central nervous system therapeutics: old challenges, new directions, and a philosophic divide","volume":"11","author":"Banks","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115270_bb0280","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.jconrel.2026.115270_bb0285","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0169-409X(95)00003-P","article-title":"Transport of small molecules through the blood-brain barrier: biology and methodology","volume":"15","author":"Pardridge","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115270_bb0290","first-page":"22","article-title":"Options when anti-depressants cannot be used in conventional ways. Clinical case and review of literature","volume":"15-16","author":"Das","year":"2019","journal-title":"Pers. Med. Psychiatry"},{"key":"10.1016\/j.jconrel.2026.115270_bb0295","doi-asserted-by":"crossref","first-page":"6525","DOI":"10.1016\/j.tetlet.2008.08.107","article-title":"Complexation of \u03b2-cyclodextrin with carborane derivatives in aqueous solution","volume":"49","author":"Ohta","year":"2008","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.jconrel.2026.115270_bb0300","article-title":"Rapid enzyme-independent catechol reactions in biologically-relevant aqueous media","volume":"2026","author":"Dieni","year":"2026","journal-title":"ChemRxiv"},{"key":"10.1016\/j.jconrel.2026.115270_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1116887","article-title":"Novel pH-sensitive catechol dyes synthesised by a three component one-pot reaction","volume":"10","author":"Calmels","year":"2023","journal-title":"Front. Chem."},{"key":"10.1016\/j.jconrel.2026.115270_bb0310","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuro.2022.07.008","article-title":"The SH-SY5Y human neuroblastoma cell line, a relevant in vitro cell model for investigating neurotoxicology in human: focus on organic pollutants","volume":"92","author":"Lopez-Suarez","year":"2022","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.jconrel.2026.115270_bb0315","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3233\/JAD-201409","article-title":"Expression and localization of A\u03b2PP in SH-SY5Y cells depends on differentiation state","volume":"82","author":"Riegerov\u00e1","year":"2021","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.jconrel.2026.115270_bb0320","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3390\/pharmaceutics14030629","article-title":"Evaluation of recent intranasal drug delivery systems to the central nervous system","volume":"14","author":"Crowe","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115270_bb0325","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1021\/acs.molpharmaceut.0c00675","article-title":"In vitro and in vivo comparison of curcumin-encapsulated chitosan-coated poly(lactic-co-glycolic acid) nanoparticles and curcumin\/hydroxypropyl-\u03b2-cyclodextrin inclusion complexes administered intranasally as therapeutic strategies for Alzheimer\u2019s disease","volume":"17","author":"Zhang","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115270_bb0330","article-title":"Potential of particle size less than 15 nm via olfactory region for direct brain delivery via intranasal route","volume":"4","author":"Handa","year":"2022","journal-title":"Health Sci. Rev"},{"key":"10.1016\/j.jconrel.2026.115270_bb0335","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1208\/s12248-015-9719-7","article-title":"Intranasal delivery of proteins and peptides in the treatment of neurodegenerative diseases","volume":"17","author":"Meredith","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2026.115270_bb0340","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2026.115270_bb0345","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/jpp\/rgac001","article-title":"Brain uptake and distribution patterns of 2-hydroxypropyl-\u00df-cyclodextrin after intrathecal and intranasal administration","volume":"74","author":"Banks","year":"2022","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115270_bb0350","doi-asserted-by":"crossref","DOI":"10.1002\/alz.71121","article-title":"A\u03b2 antibodies target not only amyloid plaques but also distinct brain cells and vessels","volume":"22","author":"Wen","year":"2026","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jconrel.2026.115270_bb0355","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1074\/jbc.M210207200","article-title":"In vitro characterization of conditions for amyloid-\u03b2 peptide oligomerization and fibrillogenesis*","volume":"278","author":"Stine","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.115270_bb0360","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41418-020-0592-2","article-title":"Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer\u2019s mice","volume":"28","author":"Santamaria","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2026.115270_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2020.12.072","article-title":"Quantitative imaging of amyloid beta peptide (A\u03b2) in Alzheimer\u2019s brain tissue by laser ablation ICP-MS using gold nanoparticles as labels","volume":"1148","author":"Gao","year":"2021","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jconrel.2026.115270_bb0370","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1007\/s00216-014-8012-4","article-title":"Quantitative bioimaging of p-boronophenylalanine in thin liver tissue sections as a tool for treatment planning in boron neutron capture therapy","volume":"407","author":"Reifschneider","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jconrel.2026.115270_bb0375","doi-asserted-by":"crossref","DOI":"10.1002\/med.70060","article-title":"Quantification of 10B and 11B in biological samples in translational science and clinical applications for boron neutron capture therapy (BNCT)","author":"Selg","year":"2026","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2026.115270_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/life13071578","article-title":"Enhanced resolution of neutron autoradiography with UV-C sensitization to study boron microdistribution in animal models","volume":"13","author":"Portu","year":"2023","journal-title":"Life"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926006747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926006747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:56:23Z","timestamp":1790211383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926006747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":76,"alternative-id":["S0168365926006747"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115270","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nose-to-brain delivery of a novel boronated curcuminoid via cyclodextrins: Biodistribution toward potential BNCT applications in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115270","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115270"}}